Low IGF-I levels in hip fracture patients: A comparison of 20 coxarthrotic and 23 hip fracture patients

Acta Orthopaedica Scandinavica

Volumn 70, Issue 2, 1999, Pages 145-148

  Hedström, Margareta ^a,b   Sääf, Maria ^b   Dalén, Nils ^a  

^a DANDERYD HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BODY COMPOSITION; BODY MASS; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CATABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; HIP FRACTURE; HIP OSTEOARTHRITIS; HUMAN; MALE; PREOPERATIVE EVALUATION;

EID: 0032952129     PISSN: 00016470     EISSN: None     Source Type: Journal    
DOI: 10.3109/17453679909011253     Document Type: Article

References (14)

1. Brismar K, Gutniak M, Povoa G, Werner S, Hall K. Insulin regulates the 35 kDA IGF binding protein in patients with diabetes mellitus. J Endocrinol Invest 1988; 11: 599-602.
2. Brismar K, Fernqvist-Forbes E, Wahrén J, Hall K. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3 and IGF-1 in insulin-dependent diabetes. J Clin Endocrinol Metab 1994; 79 (3): 872-8.
3. Brixen K, Kassem M, Fink Eriksen E, Nielsen H, Flyvbjerg A, Mosekilde L. Growth hormone (GH) and adult bone remodeling: the potential use of GH in treatment of osteoporosis. J Pediatr Endocinol 1993; 6 (1): 65-71.
4. Counts D R, Gwirtsman H, Carlsson L M, Lesem M, Cutler G B. The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs) and the IGF-binding protein. J Endocrinol Metab 1992; 75 (3): 762-7.
5. Cwyfan Hughes S, Cotterhill A, Molloy A, Casell T, Braude N, Hinds C, Wass J, Holly J. The induction of specific proteases for insulin-like growth factor-binding proteins following major heart surgery. J Endocrinol 1992; 135: 135-45.
6. Degerblad M, Póvoa G, Thorén M, Wivall I-L, Hall K. Lack of diurnal rhythm of low molecular weight insulin-like growth factor binding protein in patients with Cushing's disease. Acta Endocrinol 1989; 120: 195-200.
7. Fryburg D, Barret E. Growth hormone acutely stimulates skeletal muscle but not whole-body protein synthesis in humans. Metabolism 1993; 42 (9): 1223-7.
8. Høidrup S, Juul A, Schifter S, Skakkebaek N E, Pedersen A N, Lauritzen J B, Schroll M. Serum insulin-like growth factor (TGF-1) and IGF binding protein-3 correlate with bone mineral density in 80-year-old males but not in females. Proceedings of the World Congress of Osteoporosis 1996.
9. Johansson A, Forslund A, Hambraeus L, Blum W, Ljunghall S. Growth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men. J Bone Miner Res 1994; 9 (6): 915-21.
10. Lloyd M, Hart D, Nandra D, McAlindon T, Wheeler M, Doyle D, Spector T. Relation between insulin-like growth factor -I concentrations, osteoarthritis, bone density, and fractures in the general population: the Clingford study. Ann Rheum Dis 1996; 55: 870-4.
11. Postel-Vinay M C, Saab C, Gourmelen M. Nutritional status and growth hormone-binding protein. Horm Res 1995; 44 (4): 177-81.
12. Ross R, Miell J, Freeman E, Jones J, Matthews D, Preece M, Buchanon C. Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-1. Clin Endocrinol 1991; 35: 47-54.
13. Wüster C, Blum W F, Schlemilch S, Ranke M B, Ziegler R. Decreased serum levels of insulin-like growth factors and IGF binding protein 3 in osteoporosis. J Intern Med 1993; 234: 249-55.
14. Zapf J. Total and free IGF serum levels. Eur J Endocrinol 1997; 136: 146-7.